Business · 29/11/2004Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on HIV Drug Resistance Testing for Antiretroviral Drug Development
Summary
The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop new treatments for HIV infection, focusing on the role of HIV resistance testing in the drug development process.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →